SUBJECTS : Leukemia | Lymphoma | Multiple Myeloma | Hematologic Malignanc
Leukemia Research Reports: 2023, vol: 19, issue:
- 1)- Jumoke Okikiolu, Claire Woodley, Llywelyn Cadman-Davies, Jennifer O'Sullivan, Deepti Radia, Natalia Curto Garcia, Patrick Harrington, Shahram Kordasti, Susan Asirvatham, Priya Sriskandarajah, Jamie Saunders, Chandan Saha, Irene Sanchez, Hugues deLavallade, Donal P McLornan, Claire N Harrison. Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys). Leukemia research reports. 2023, 19: 100360
Cited : 5Read More - 2)- Dorela Lame, Michelangelo Pianelli, Erika Morsia, Alberto Carturan, Gaia Goteri, Stefania Mancini, Attilio Olivieri, Antonella Poloni. A rare case of aCML associated with CNS involvement and with aggressive clinical course. Leukemia research reports. 2023, 19: 100361Cited : 1Read More
- 3)- Bengt Zöller, Eric Manderstedt, Christina Lind-Halldén, Christer Halldén. Contribution of rare and common coding variants to haematological malignancies in the UK biobank. Leukemia research reports. 2023, 19: 100362Cited : 1Read More
- 4)- Rohit Singh, David Alejos, Casey Rankins, Katherine A Devitt, Joanna L Conant, Diego Adrianzen-Herrera. Isolated bone marrow gamma-delta T-Cell lymphoma: Another challenge to the WHO lymphoid neoplasm classification. Leukemia research reports. 2023, 19: 100363Cited : 0Read More
- 5)- Josephine Emole, Odunayo Lawal, Oleksandra Lupak, Hemalatha Rangarajan, Itoro Udo. Neuropsychiatric disorders in adults undergoing chimeric antigen receptor T cells therapy for aggressive lymphomas and acute lymphoblastic leukemia. Leukemia research reports. 2023, 19: 100364Cited : 0Read More
- 6)- Ryo Yonezawa, Kazushi Shimamoto, Nobuyuki Kabasawa, Mizuki Sano, Shizuko Tanaka, Mitsuki Matsui, Hiroshi Harada, Tomiko Sunaga. A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma. Leukemia research reports. 2023, 19: 100365Cited : 1Read More
- 7)- Félicité de Charry, Johanna Konopacki, Sarah Bugier, Vincent Foissaud, Ivan Sloma, Jean-Valère Malfuson, Pierre Arnautou. Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia. Leukemia research reports. 2023, 19: 100366Cited : 0Read More
- 8)- Shiqiang Qu, Yiru Yan, Chengwen Li, Zefeng Xu, Wenyu Cai, Tiejun Qin, Peihong Zhang, Yujiao Jia, Lijuan Pan, Qingyan Gao, Bing Li, Jinqin Liu, Meng Jiao, Zhijian Xiao. Case of cryptic rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy. Leukemia research reports. 2023, 19: 100367Cited : 0Read More
- 9)- Minh Phuong Vu, Thi Van Oanh Kieu, Hoang Vu. Consolidation and maintenance therapy with bortezomib for Vietnamese patients with multiple myeloma after autologous transplantation. Leukemia research reports. 2023, 19: 100368Cited : 0Read More
- 10)- Süreyya Yiğit Kaya, Abdullah Emre Askin, Sebnem Bektas, Aslı Çakır, Ömür Gökmen Sevindik. Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder. Leukemia research reports. 2023, 19: 100369Cited : 0Read More
- 11)- Dong Chen, Guang Liu, Michael R Lewis, Xia Li, Matthew Ulrickson, Rajneesh Nath, Weina Chen. Myeloid/lymphoid neoplasm with rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations. Leukemia research reports. 2023, 19: 100370Cited : 0Read More
- 12)- Lyndsey Sandow, Michael Heinrich. Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia. Leukemia research reports. 2023, 19: 100371Cited : 0Read More
- 13)- Dariusz Uczkowski, Hamza Ashraf, Mohamad Cherry, Nikolay Dimov. Gray zone lymphoma: A case report and comprehensive review of literature. Leukemia research reports. 2023, 19: 100372Cited : 3Read More
- 14)- Brian A Jonas, Laura A Potter, Maria Galkin, Joseph M Tuscano. A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML. Leukemia research reports. 2023, 19: 100374Cited : 1Read More
